ABCB1 and ovarian cancer: Previous studies have shown that knockdown of the ABCB1 gene can re-sensitize and increase the intracellular accumulation of chemotherapeutics in drug-resistant ovarian cancer cells, making it a suitable target for treatment [22,23].